Inregen
Records under this name other than the patents Inregen holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,192,629 | Isolated Renal Cells and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,105,392 | Isolated Renal Cells and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,318,484 | Isolated Renal Cells and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,724,367 | Injectable Formulations for Organ Augmentation Formerly held In force · High confidence | In force | High confidence | |
| US 10,363,274 | Renal Cell Populations and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,369,639 | Renal Cell Populations and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,409,191 | Renal Cell Populations and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 7,918,897 | Scaffolds for organ reconstruction and augmentation Formerly held Lapsed on the fee record Ended Apr 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 5, 2023 | From the USPTO record |
| US 8,337,485 | Cell-scaffold constructs Formerly held Lapsed on the fee record Ended Dec 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | From the USPTO record |
| US 9,271,824 | Cell scaffold constructs Formerly held Lapsed on the fee record Ended Mar 1, 2020 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2020 | From the USPTO record |